Together, we will do this.
Life sciences companies have three overarching goals
Accelerating speed to market
Launching and successfully penetrating the market with safe and effective drugs, vaccines and medical devices
Improving health
Ensuring that the right patients are on the right therapies, at the right time
Proving the value of its products
Assessing the impact of its products on patient health outcomes and total cost of care
Obtaining these objectives, however, is fraught with challenges.
Introducing EXL Health life sciences
Human Ingenuity is the catalyst with which EXL Health solves your complex problems. We combine our extensive patient-, consumer-, and HCP-level data assets, advanced analytics methodologies, and domain expertise to find better ways to discover and keep patients on your therapies.
We are client focused, always looking and going deeper to find a better way to address your specific challenges effectively and efficiently. We act nimbly, rapidly evaluating, identifying, and implementing solutions using our proven framework. Our team adapts quickly to industry and regulatory changes, and adopts new techniques and technologies to meet your specific needs, accelerate your transformation into value-based care, and support your continued success.
Our innovative, tailored solutions are developed through collaborative engagement focused on your current and dynamic business challenges. This approach results in much more than a transaction. Through it, we establish and nurture long-term, forward-thinking business relationships - true partnerships. Together, We Will Do This is more than just a marketing headline - it’s a commitment, our promise to you.
Driving value with data
The core excellence in analytics is expertise in data. EXL Health processes over 27 terabytes of data monthly. Rigorous data quality practices assure the efficiency and availability of data for use in developing analytic models, designing programs, and delivering results. In addition to managing disparate data at scale, EXL Health has developed a 44M+ patient benchmark database representing Commercial, Medicare and Medicaid lines of business. This data, coupled with our AI/machine learning, natural language processing, and data visualization and interactive dashboard tools, offers unique insights in not only what happened, but what may happen and what to do about it.
- Brand teams are pressured to maximize their products’ commercial success by understanding patient personas and provider rankings, finding undiagnosed patients, decreasing non-adherence, and changing their products’ line of therapy position.
- Market access and managed markets strategists need to prove the cost effectiveness of their products as compared to competing products to establish and enhance value-based relationships with payer, provider and PBM partners.
- Marketing and sales teams need to target the right audiences with the right messages through preferred channels, optimizing ROI.



Proven outcomes: human ingenuity at work
Here are just a few examples of how our talent combines data, analytics, technology, and our domain expertise to deliver value to life sciences companies:
Top 10 global pharma company
Value-based contracting
Delivered innovative value-based case analytics, including Total Cost of Care and Patient Treatment Journey analysis for the Type 2 Diabetes market, to support decisions on which patient segments to focus on, how to position and structure value-based contracts, and how to measure performance/ outcomes.
Top 10 global pharma company
Market access strategy development
Developed a 360º, comprehensive approach for patient persona and provider profiles to negotiate formulary status in high-value markets, understand clinical and financial risk of impactable patient populations, target HCPs, and develop multi-channel marketing strategies.
Top 10 global pharma company
Patient journey analysis
Identified patient treatment journeys and healthcare providers’ clinical treatment pathways for Non-Small Cell Lung Cancer (NSCLC) to identify HCPs’ preferred lines of treatment, quantify utilization of medical pharmacy services, and develop/ augment a target list of HCPs based on understanding the providers’ therapeutic care of their NSCLC patients.
"This EXL Health cost of care platform is amazing and provides my team with the local level patient insights to help inform our Payer Marketings plans. The dashboard enables me to define custom patient cohorts for metric comparisons, and the charts and maps show clearly where to focus our attention."